Association between ABO blood groups and rhesus antigen and susceptibility to COVID-19 in the Yazd hospital.
Age
COVID-19
blood groups
gender
rhesus antigen
Journal
New microbes and new infections
ISSN: 2052-2975
Titre abrégé: New Microbes New Infect
Pays: England
ID NLM: 101624750
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
30
05
2021
revised:
11
08
2021
accepted:
16
08
2021
pubmed:
7
9
2021
medline:
7
9
2021
entrez:
6
9
2021
Statut:
ppublish
Résumé
Blood group antigens are one of the most important antigens in humans that have an impact on susceptibility to disease and may be used as a prognosis factor in different diseases such as COVID-19. The study aimed to investigate the relationship between ABO blood groups and Rhesus antigen and susceptibility to COVID-19. The clinical data of 398 subjects were used in the investigation collected from 148 cases vs. 250 controls. This information was obtained from Shahid Sadoughi Hospital of Yazd (IRAN) University. Blood groups and outcomes were assessed using statistical tests for four populations: COV + vs. COV- and COV +/deceased vs. COV +/live. Out of a total of 148 COVID-19 patients, 80 (54/1%) were male, 68 (45/9%) were female. Among these patients, 33 (22/6%) had type A+, 44 (30/1%) had type B+, 13 (8/9%) had type AB+, and 36 (24/7%) had type O+. On the other hand, out of 148 patients, 126 (86/3%) had positive blood types, and 20 (13/7%) had negative blood types. As a result, no significant difference was found in the relationship between ABO blood groups and RH type and susceptibility to COVID-19 (p-value = 0.392 and p-value = 0.847, respectively). Other data showed a significant difference between patients group with other parameters such as age (p-value<0.001) and gender (p-value<0.001). Although in this study there was no association between blood type and RH type with COVID-19, findings of the association between age and gender can confirm the results of previous studies.
Identifiants
pubmed: 34484798
doi: 10.1016/j.nmni.2021.100934
pii: S2052-2975(21)00098-6
pmc: PMC8409054
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100934Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
All authors declared that they have no conflict of interest.
Références
Mil Med Res. 2020 Mar 13;7(1):11
pubmed: 32169119
Nat Commun. 2020 Nov 13;11(1):5761
pubmed: 33188185
Front Cell Infect Microbiol. 2020 Jul 21;10:404
pubmed: 32793517
J Gastroenterol Hepatol. 2020 May;35(5):744-748
pubmed: 32215956
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Blood. 2010 Jun 10;115(23):4635-43
pubmed: 20308598
Endocr Res. 2020 Feb - May;45(2):137-146
pubmed: 31760829
Stem Cell Rev Rep. 2021 Jun 28;:
pubmed: 34181186
Ann Hematol. 2020 Sep;99(9):2113-2118
pubmed: 32656591
JAMA. 2005 Mar 23;293(12):1450-1
pubmed: 15784866
Blood Transfus. 2013 Oct;11(4):491-9
pubmed: 24120598
Turk J Med Sci. 2020 Jun 4;50(4):679-683
pubmed: 32496734
Clin Chim Acta. 2020 Oct;509:220-223
pubmed: 32562665
Am J Trop Med Hyg. 2016 Aug 3;95(2):263-264
pubmed: 27402512